February 2, 2015
Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Expands Overseas Distribution of ORONAMIN C DRINK Carbonated nutritional beverage to be produced and sold in South Korea
- Expansion of overseas distribution aims to deliver the "vitality" of ORONAMIN C DRINK to an ever-increasing number of people around the world. February 2, 2015 marks the debut of the carbonated nutritional beverage in South Korea, a rapidly growing market for nutritional drinks.
- Since its initial launch in February 1965, a cumulative total of more than 30 billion bottles of ORONAMIN C DRINK have been sold in Japan and in six Middle Eastern markets. The carbonated nutritional beverage is rapidly becoming a global brand that is favored by adults and children alike.
- Otsuka Group affiliate Dong-A Otsuka Co., Ltd. will be in charge of ORONAMIN C DRINK production and sales in South Korea. Otsuka Pharmaceutical aims to continue to deliver the vitality of ORONAMIN C DRINK in keeping with the culture and customs around the world, with a main focus on Asia and the Middle East.
Otsuka Pharmaceutical Co., Ltd. (Head Office: Tokyo, Japan; President: Taro Iwamoto) has announced the February 2, 2015 launch of ORONAMIN C DRINK (ORONAMIN C) in South Korea. The carbonated nutritional beverage will be produced and sold by Otsuka's affiliate Dong-A Otsuka Co., Ltd., which also produces and sells POCARI SWEAT for the South Korean market. This will be the first ORONAMIN C production facility outside of Japan.
Information in this news release was current as of the original release date.